Has Brian Wu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,248 in general payments to Brian Wu, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Wu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Wu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Wu, MD

Psychiatry · Riverside, CANPI 1033637236

Payments from drug & device makers

$2,248in general payments, 2019–2025

Across 4 payments — averaging $562.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neuronetics, Inc.$2K
Acadia Pharmaceuticals Inc$148

What the payments were for

Travel & lodging$1,23055%
Food & beverage$1,01945%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neuronetics, Inc.	3	$2,101
Acadia Pharmaceuticals Inc	1	$148

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEUROSTAR TMS THERAPY SYSTEM$2,101
NUPLAZID$148

How this compares

$2,248 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Medicare billing

Part B allowed, 2024

$439,431

Medicare patients

1,932

Services billed

3,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	35	$114,621
Quetiapine Fumarate ErQuetiapine Fumarate	31	$22,255
VraylarCariprazine Hcl	12	$16,036
TrintellixVortioxetine Hydrobromide	11	$5,555
Olanzapine	89	$5,467
Divalproex Sodium	81	$4,106
Clozapine	72	$3,977
Mirtazapine	95	$3,510
Duloxetine Hcl	30	$3,312
Ziprasidone Hcl	11	$2,468
Divalproex Sodium ErDivalproex Sodium	29	$1,875
Buspirone Hcl	88	$1,781
Haloperidol	40	$1,691
Lurasidone Hcl	17	$1,449
Quetiapine Fumarate	51	$1,423

Paid to pharmacies, not to this prescriber.

Other psychiatry in Riverside

Evagelos CoskinasRiverside$7.3M
Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →